相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effects of Adjuvants on HIV-1 Envelope Glycoprotein SOSIP Trimers In Vitro
Gabriel Ozorowski et al.
JOURNAL OF VIROLOGY (2018)
Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches
Matthias Pauthner et al.
IMMUNITY (2017)
The quest for an antibody-based HIV vaccine
Barton F. Haynes et al.
IMMUNOLOGICAL REVIEWS (2017)
Use of broadly neutralizing antibodies for HIV-1 prevention
Amarendra Pegu et al.
IMMUNOLOGICAL REVIEWS (2017)
Native-like Env trimers as a platform for HIV-1 vaccine design
Rogier W. Sanders et al.
IMMUNOLOGICAL REVIEWS (2017)
An HIV Vaccine Is Essential for Ending the HIV/AIDS Pandemic
Anthony S. Fauci
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Randomized, Double-Blind Evaluation of Late Boost Strategies for HIV-Uninfected Vaccine Recipients in the RV144 HIV Vaccine Efficacy Trial
Supachai Rerks-Ngarm et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
HIV Developing an HIV vaccine What are the paths and obstacles to a practical vaccine?
Barton F. Haynes et al.
SCIENCE (2017)
Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques
Ling Xu et al.
SCIENCE (2017)
What Are the Most Powerful Immunogen Design Vaccine Strategies? Reverse Vaccinology 2.0 Shows Great Promise
Dennis R. Burton
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2017)
Adjuvants: tailoring humoral immune responses
M. Juliana McElrath
CURRENT OPINION IN HIV AND AIDS (2017)
HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimers
Silvia Capucci et al.
PLOS ONE (2017)
Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design
Jason Gorman et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)
Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design
Jason Gorman et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)
Combination HIV prevention options for young women in Africa
Cheryl Baxter et al.
AJAR-AFRICAN JOURNAL OF AIDS RESEARCH (2016)
HIV-Host Interactions: Implications for Vaccine Design
Barton F. Haynes et al.
CELL HOST & MICROBE (2016)
Germinal Center B Cell and T Follicular Helper Cell Responses to Viral Vector and Protein-in-Adjuvant Vaccines
Chuan Wang et al.
JOURNAL OF IMMUNOLOGY (2016)
Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition
Monica Vaccari et al.
NATURE MEDICINE (2016)
Approaches to the induction of HIV broadly neutralizing antibodies
Penny L. Moore et al.
CURRENT OPINION IN HIV AND AIDS (2016)
Direct Probing of Germinal Center Responses Reveals Immunological Features and Bottlenecks for Neutralizing Antibody Responses to HIV Env Trimer
Colin Havenar-Daughton et al.
CELL REPORTS (2016)
Broad HIV-1 inhibition in vitro by vaccine-elicited CD8(+) T cells in African adults
Gaudensia Mutua et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2016)
Immune perturbations in HIV-1-infected individuals who make broadly neutralizing antibodies
M. Anthony Moody et al.
SCIENCE IMMUNOLOGY (2016)
Lessons from the RV144 Thai Phase III HIV-1 Vaccine Trial and the Search for Correlates of Protection
Jerome H. Kim et al.
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems Serology
Amy W. Chung et al.
CELL (2015)
Identification of Common Features in Prototype Broadly Neutralizing Antibodies to HIV Envelope V2 Apex to Facilitate Vaccine Design
Raiees Andrabi et al.
IMMUNITY (2015)
Antigenicity and Immunogenicity of a Trimeric Envelope Protein from an Indian Clade C HIV-1 Isolate
Rangasamy Sneha Priya et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodies
Jinal N. Bhiman et al.
NATURE MEDICINE (2015)
Cleavage-Independent HIV-1 Env Trimers Engineered as Soluble Native Spike Mimetics for Vaccine Design
Shailendra Kumar Sharma et al.
CELL REPORTS (2015)
Nonneutralizing Functional Antibodies: a New Old Paradigm for HIV Vaccines
Jean-Louis Excler et al.
CLINICAL AND VACCINE IMMUNOLOGY (2014)
Vaccine-elicited Human T Cells Recognizing Conserved Protein Regions Inhibit HIV-1
Nicola Borthwick et al.
MOLECULAR THERAPY (2014)
Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies
Nicole A. Doria-Rose et al.
NATURE (2014)
Stable, uncleaved HIV-1 envelope glycoprotein gp140 forms a tightly folded trimer with a native-like structure
James M. Kovacs et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Vaccine-elicited primate antibodies use a distinct approach to the HIV-1 primary receptor binding site informing vaccine redesign
Karen Tran et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Squalene-adjuvanted H7N9 virus vaccine induces robust humoral immune response against H7N9 and H7N7 viruses
Chia-Ying Wu et al.
VACCINE (2014)
Multiple Pathways of Escape from HIV Broadly Cross-Neutralizing V2-Dependent Antibodies
Penny L. Moore et al.
JOURNAL OF VIROLOGY (2013)
Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120
Leopold Kong et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2013)
Cleavage strongly influences whether soluble HIV-1 envelope glycoprotein trimers adopt a native-like conformation
Rajesh P. Ringe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
The adjuvant effect of MF59 is due to the oil-in-water emulsion formulation, none of the individual components induce a comparable adjuvant effect
Samuele Calabro et al.
VACCINE (2013)
Broadly neutralizing antibodies against HIV-1: Templates for a vaccine
Marit J. van Gils et al.
VIROLOGY (2013)
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
Barton F. Haynes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9
Jason S. McLellan et al.
NATURE (2011)
The porcine circovirus type 1 capsid gene promoter improves antigen expression and immunogenicity in a HIV-1 plasmid vaccine
Fiona L. Tanzer et al.
VIROLOGY JOURNAL (2011)
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Supachai Rerks-Ngarm et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Correlates of vaccine-induced immunity
Stanley A. Plotkin
CLINICAL INFECTIOUS DISEASES (2008)
Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro
GL Morefield et al.
VACCINE (2005)
Stabilization of the soluble, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1
RW Sanders et al.
JOURNAL OF VIROLOGY (2002)
Enhancing the proteolytic maturation of human immunodeficiency virus type 1 envelope glycoproteins
JM Binley et al.
JOURNAL OF VIROLOGY (2002)
分享论文
